Home » Oncology Clinical Trials » Current Clinical Trials

Current Clinical Trials

clinical_trials_Banner1

Clinical Trials:

Principal Investigators listed are Beacon Hospital PIs

Open for Recruitment

Breast Cancer:

ICORG 10-15 Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

  • Principal Investigator: Dr. Jennifer Westrup
  • ClinicalTrials.gov Identifier NCT 01840306

> Click here for more info

ICORG 10-16 A Study To Determine Alteration of Hormone Levels in Premenopausal Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy For Breast Cancer

  • Principal Investigator: Dr. Jennifer Westrup
  • ClinicalTrials.gov Identifier NCT 01726322

> Click Here for more info


Colorectal Cancer:

ICORG 12-27 Identification of Plasma Biomarkers in Early Detection of Colorectal Adenocarcinoma Recurrence (C-RAC Plasma Biomarker Study)

  • Principal Investigator: Dr.Ray McDermott
  • ClinicalTrials.gov Identifier NCT 02050737

> Click here for more info


Pancreatic Cancer:

ICORG 12-31 Identification of Predictive Plasma Biomarkers in Pancreatic Ductal Adenocarcinoma (PDAC Plasma Biomarker Study)

  • Principal Investigator: Dr.Ray McDermott
  • ClinicalTrials.gov Identifier NCT 02050997

> Click here for more info


Prostate Cancer:

CTRIAL-IE 18-02 NRG GU005 Phase III IGRT & SBRT VS IGRT & Hypofractionated IMRT For Localised Intermediate Risk Prostate Cancer

  • Principal Investigator: Dr.Alina Mihai

> Click here for more info

CTRIAL-IE 17-30 IRONMAN: International Registry for Men with Advanced Prostate Cancer

  • Principal Investigator: Prof.Ray McDermott
  • ClinicalTrials.Gov Identifier NCT03151629

> Click here for more info

Coming Soon: Not Yet Recruiting

CTRIAL-IE 15-47 INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

  • Principal Investigator: Prof.John Armstrong

> Click here for more info

Closed for Recruitment

Prostate Cancer:

ICORG 06-15 Proteomic Analysis Of The Combined Hormonal Therapy And Radiation Therapy For Localised Prostate Cancer

  • Principal Investigator: Prof. John Armstrong
  • ClinicalTrials.gov Identifier NCT 00955435

> Click here for more info


FE 200486 CS39 “A Prospective Observational Safety Study in Patients with Advanced Prostate Cancer Treated with Firmagon® (Degarelix) or a GnRH Agonist” E-Study Protocol-848;Ver.1.0 

  • Principal Investigator: Dr.Alina Mihai
  • This is a study involving patients that are prescribed Firmagon as a first line treatment as part of their prostate cancer management and followed up during their routine standard of care.

ICORG 08-17 A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer

  • Principal Investigators: Prof. John Armstrong and  Dr.Alina Mihai
  • ClinicalTrials.gov Identifier: NCT 00951535

> Click here for more info


ICORG 14-06 Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET)

  • Principal Investigator: Dr.Ray McDermott
  • ClinicalTrials.gov Identifier NCT 02446405

> Click here for more info


ICORG 15-43 Clinical Research Questionnaire of Oncology Patients-A Nationwide Survey

  • Principal Investigator: Dr.Alina Mihai
  • This is a 10 minute anonymous questionnaire that oncology patients can complete that examines what cancer patients know about cancer research and what drives their decisions about taking part in cancer research.

ICORG 14-04 “Irish Programme for Stratified Prostate Cancer Therapy iPROSPECT” V 1.1 02-February-2015

  • Principal Investigator: Prof. John Armstrong
  • This study is in relation to both the identification of predictive biomarkers for androgen deprivation therapy (ADT) treatment or ADT combined treatment response in metastatic prostate cancer (mPCa) and identification of predictive biomarker(s) for treatment response in metastatic castration resistant prostate cancer (mCRPC).

CTRIAL-IE 14-07 Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer (ENZARAD)

  • Principal Investigator: Dr. Alina Mihai

> Click here for more info


CTRIAL-IE 14-06 Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET)

  • Principal Investigator: Prof. Ray McDermott

> Click here for more info


CTRIAL-IE 15-46 Prostate Advances in Comparative Evidence (PACE) International Randomised Study of Prostatectomy vs Stereotactic Body Radiotherapy (SBRT) and Conventional Radiotherapy vs SBRT for Early Stage Organ-confined Prostate Cancer

  • Principal Investigator: Dr. Alina Mihai

> Click here for more info

Prostate Cancer:

ICORG 14-07 Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer (ENZARAD)

  • Principal Investigator: Dr.Alina Mihai
  • ClinicalTrials.gov Identifier NCT 02446444

> Click here for more info


Oligometastatic Disease:

ICORG 15-05 (UPCI 10-028) Radiosurgery for Patients With Recurrent Oligometastatic Disease

  • Principal Investigator: Dr.Alina Mihai
  • ClinicalTrials.gov Identifier NCT 01345552

> Click here for more info